Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.43 - $33.43 $943,453 - $1.24 Million
37,100 Added 31.47%
155,000 $3.98 Million
Q1 2024

May 15, 2024

BUY
$26.23 - $34.14 $1.56 Million - $2.03 Million
59,500 Added 101.88%
117,900 $3.8 Million
Q4 2023

Feb 14, 2024

BUY
$26.98 - $32.18 $893,038 - $1.07 Million
33,100 Added 130.83%
58,400 $1.88 Million
Q3 2023

Nov 14, 2023

BUY
$31.47 - $39.94 $264,348 - $335,496
8,400 Added 49.7%
25,300 $808,000
Q2 2023

Aug 14, 2023

SELL
$31.6 - $37.62 $176,960 - $210,672
-5,600 Reduced 24.89%
16,900 $573,000
Q1 2023

May 15, 2023

SELL
$33.31 - $38.75 $223,177 - $259,625
-6,700 Reduced 22.95%
22,500 $807,000
Q4 2022

Feb 14, 2023

BUY
$31.11 - $41.31 $40,443 - $53,703
1,300 Added 4.66%
29,200 $995,000
Q3 2022

Nov 14, 2022

SELL
$35.66 - $42.98 $966,385 - $1.16 Million
-27,100 Reduced 49.27%
27,900 $995,000

Others Institutions Holding PRGO

About PERRIGO Co plc


  • Ticker PRGO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 134,618,000
  • Market Cap $3.55B
  • Description
  • Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment ...
More about PRGO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.